Redcliffe Labs appoints Ishaan Khanna as Director-Reproductive Medicine & Genetics

Khanna's last assignment was as CEO, Biobank and Diagnostics at Lifecell where he spent over a decade

New Delhi: Redcliffe Labs, a unit of Redcliffe Lifetech in the U.S. and India, recently announced the appointment of Ishaan Khanna as Director – Reproductive Medicine and Genetics.
Ishaan is a techno-commercial leader with over 19 years of experience in institutional and commercial healthcare businesses. He has effectively built organizations from the ground up and demonstrated success in establishing successful; diagnostic business models in India and abroad.
He started his career as scientist with assignments spanning across Australia and UK. After coming back to India he worked in Business development leadership roles in Biotech and pharma companies such as Avesthagen and Krishna Antioxidants.
His last assignment was at Lifecell where he was the CEO, Biobank and Diagnostics where he spent over a decade.
He also brought some of the key diagnostic platforms to India for the first time such as QFPCR and rapid genetic testing to support the need of sick infants and pregnant women and building leadership in domains such as newborn screening. In his previous roles he has built pan India network of labs and efficient networks, something which he wishes to do at a much larger scale at Redcliffe.
It is also noteworthy to mention that Ishaan has been facilitated with various awards such as the Best Healthcare CEO, Sustainability leader and Start-up Baron.
Ishaan is a Gold Medalist in Bachelors Biotechnology, Manipal University, Kasturba Medical College/ Manipal Lifescience School India; and holds Masters in Biotechnology and Masters in Enterprise, University of Manchester.
Welcoming Ishaan Khanna, Dheeraj Jain, the Founder of Redcliffe Labs said, “Ishaan comes with a rich experience and his work reflects his interest in taking healthcare to the masses, which is exactly in sync with Redcliffe’s philosophy. We are confident that he will perfectly lead this role.
This appointment is also important as the Reproductive Medicine and Genetics market continues to grow and evolve, offering great opportunities for players like us in this space. As we continue to experience strong growth momentum, we feel having the right team is key.”
“I am honoured to be associated with Redcliffe Labs at a time when the healthcare and genetics industry in India is witnessing upward growth. I am looking forward to be a part of Redcliffe team and its growth story.” said the newly appointed Director – Reproductive Medicine and Genetics at Redcliffe Labs, Ishaan Khanna.